logo

For the Inventor, By the Inventor

Harleysville, PA, United States of America

Richard C Isaacs

This inventor holds 12 USPTO granted patents and 1 published patent application. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Sloan-Kettering Institute for Cancer Research. Active years: 1997-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard C Isaacs. Retrieved from https://idiyas.com/inventor/richard-c-isaacs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 58.3

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 42(Granted Patents)


Company Filing History:

goldMedal6 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal5 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 519 
 
Sloan-Kettering Institute for Cancer Research
 patents

Years Active: 1997-2011

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7906521 - Quinazoline potassium channel inhibitors (2011-03-15),
2. 7879839 - Potassium channel inhibitors (2011-02-01),
3. 7781457 - Isoquinolinone potassium channel inhibitors (2010-08-24),
4. 7763614 - Isoquinoline potassium channel inhibitors (2010-07-27),
5. 7741322 - Isoquinolinone potassium channel inhibitors (2010-06-22),
6. 6462050 - Thrombin inhibitors (2002-10-08),
7. 6387911 - Pyrazinone thrombin inhibitors (2002-05-14),
8. 5932606 - Pyrazinone, pyridinone, piperidine and pyrrolidine thrombin inhibitors (1999-08-03),
9. 5747540 - HIV protease inhibitors useful for the treatment of AIDS (1998-05-05),
10. 5744486 - Pyridinone thrombin inhibitors (1998-04-28),
11. 5668289 - Pyridinone thrombin inhibitors (1997-09-16),
12. 5597931 - Total synthesis of taxol and analogues thereof (1997-01-28),

Title: The Innovations of Richard C. Isaacs

Introduction

Richard C. Isaacs is a notable inventor based in Harleysville, PA (US). He has made significant contributions to the field of pharmacology, particularly in the development of potassium channel inhibitors. With a total of 12 patents to his name, Isaacs has focused on creating compounds that can effectively treat cardiac arrhythmias.

Latest Patents

Among his latest patents are two key inventions: Quinazoline potassium channel inhibitors and Potassium channel inhibitors. The first patent relates to compounds that are useful as potassium channel inhibitors to treat cardiac arrhythmias and similar conditions. The second patent also focuses on compounds with a specific structure that serve as potassium channel inhibitors for the same medical purpose.

Career Highlights

Isaacs has had a distinguished career, working with prominent companies such as Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Isaacs has collaborated with several esteemed colleagues throughout his career, including Bruce D. Dorsey and Christopher J. Dinsmore. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Richard C. Isaacs stands out as an influential inventor in the field of pharmacology, with a focus on potassium channel inhibitors. His contributions have the potential to significantly improve treatments for cardiac arrhythmias.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…